QuidelOrtho (QDEL) stock fell, despite positive mentions in investor letters and a "Hold" consensus rating.

QuidelOrtho (QDEL) stock fell despite Aristotle Capital Boston LLC's Small Cap Equity Strategy highlighting it in its Q1 2024 investor letter. The company received a consensus rating of "Hold" from seven brokerages covering it, with an average 12-month price target of $59.00. Analysts like William Blair, Royal Bank of Canada, and JPMorgan Chase & Co. have issued ratings and price targets for QDEL.